Home › Free Stock Grades › ASMB
Assembly Biosciences, Inc. (ASMB) Stock Grade
ASMB · Healthcare
A+
Market Cap
$381.3M
P/E Ratio
—
Revenue Growth (YoY)
+153.5%
Net Margin
-8.5%
Return on Equity
—
Dividend Yield
None
About Assembly Biosciences, Inc.'s fundamentals
Assembly Biosciences is a biotech company with a market capitalization of $381.3 million that reported strong revenue growth of 153.5% year-over-year, indicating rapidly expanding business activity. However, the company operates at a net margin of -8.5% and reported a net loss in its latest annual statement, meaning it is not yet profitable. The company does not pay a dividend, which is typical for early-stage biotech firms reinvesting losses into research and development.